The diagnosis and treatment of fibromuscular dysplasia (FMD) is challenging due to its heterogeneous clinical presentations and variable vascular involvement. Although there has been an increase in published research from large international registries to aid in the care of patients with FMD, the complexity of disease management necessitates multidisciplinary collaboration to optimize patient outcomes. Multidisciplinary teams, often including vascular medicine specialists, vascular surgeons, primary care providers, cardiologists, nephrologists, neurologists, noninvasive vascular laboratory, radiology, interventionalists, cardiovascular genetic counselors, pharmacists, and mental health care providers, collaborate using team-based models composed of coordinated visits for comprehensive and efficient evaluation, systematic imaging, and individualized management. Patient advocacy organizations also play a key role in the care of patients. Clinical care coordinators are instrumental in reinforcing individualized care plans and patient education. Vascular care centers are strongly encouraged to adopt such multidisciplinary, team-based care models using structured workflows, care coordination, and patient-centered approaches to advance FMD knowledge and care.